Low doses of cps49 and flavopiridol combination as potential treatment for advanced prostate cancer

Florencia Zalazar, Paola De Luca, Kevin Gardner, William D. Figg, Roberto Meiss, Raúl G. Spallanzani, Pablo Vallecorsa, Belén Elguero, Javier Cotignola, Elba Vazquez, Adriana De Siervi*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Low doses of cps49 and flavopiridol combination as potential treatment for advanced prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry